Chronic Obstructive Pulmonary Disease
The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
What is Chronic Obstructive Pulmonary Disease?
Chronic obstructive pulmonary disease (COPD) is an assortment of lung disorders that includes...
In a recent medRxiv preprint paper, researchers from the UK discussed how they determined organ impairment rates post recovery from COVID-19-related hospitalization and compared the results with that in a control group.
Owlstone Medical, the leader in Breath Biopsy® for applications in disease detection, today introduced the Respiratory Diseases Research Use Only Panel.
Can face masks protect against SARS-CoV-2 infection? Faruque Ahmad, MD, recently explored the role of face masks in mitigating the coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2.
Despite the progress made in managing asthma and chronic obstructive pulmonary disease (COPD), poorly controlled symptoms for both respiratory diseases can lead to severe shortness of breath, hospitalizations or even death.
Researchers in the United States have conducted genetic correlation studies revealing novel traits associated with the development of severe coronavirus disease 2019 (COVID-19).
A new study compares rehabilitation outcomes between COVID-19 patients and those with ordinary pneumonia, to evaluate the effectiveness of interventions.
Researchers have revealed some of the effects of cigarette smoke and chronic obstructive pulmonary disease (COPD) on SARS-CoV-2 infection.
Noncommunicable diseases now make up 7 of the world's top 10 causes of death, according to WHO's 2019 Global Health Estimates, published today.
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
A team of researchers from the Epidemiology Department, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia, has found no correlations between adult male and female smoking prevalence with COVID-19 mortality across countries. In lower-middle-income countries, however, there is a link between adult male smoking prevalence with COVID-19-related death.
Researchers in the United States have conducted a detailed analysis examining whether smoking increases or decreases the risk of testing positive for coronavirus disease 2019 (COVID-19).
Chronic obstructive pulmonary disease (COPD) is a lung disease caused by long-term inhalation of harmful gases such as cigarette smoke.
Mitochondrial protein ALDH4A1 has been identified as an autoantigen implicated in atherosclerosis.
A research team has reviewed the existing literature on compounds derived from molluscs used for treating respiratory diseases.
Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men.
Researchers duo Emma Derbyshire and Joanne Delange from the Nutritional Insight, Surrey, United Kingdom, explore the role of immunonutrition – nutrition that boosts or influences the immune system for those over 65 years of age in COVID-19. Their study titled, “COVID-19: is there a role for immunonutrition, particularly in the over 65s?,” was released in the latest issue of the BMJ Nutrition, Prevention and Health.
Researchers in Canada have conducted a study suggesting that novel Cannabis sativa extracts may decrease levels of the host cell receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain viral entry to target tissues.
A recent review of COVID-19 therapies explores the utility of interferons in the battle against severe COVID-19, and concludes that they deserve further development.
An estimated 16.4 million Americans are living with chronic obstructive pulmonary disease – a chronic lung disease that makes it difficult to breathe – which places them at an increased risk for more severe illness from COVID-19.
Research led by the Centenary Institute, the University of Technology Sydney and the University of Queensland has shown for the first time a link between chronic obstructive pulmonary disease (COPD), an often fatal lung condition, and the gut microbiome.